Paliperidone is a selective blocking agent of monoamine effects, whose pharmacological properties are different from that of traditional neuroleptics. 
It is indicated for the treatment of schizophrenia in adults and in adolescents 15 years and older.
It is also indicated for the treatment of psychotic or manic symptoms of schizoaffective disorder in adults. Effect on depressive symptoms has not been demonstrated.
Under Development
Active ingredient Pharmaceutical form Package Therapeutic target
  • Paliperidone LAI
  • Long-Acting Injectable
  • 25mg/vial
  • 50mg/vial
  • 75mg/vial
  • 100mg/vial
  • 150mg/vial
  • Antipsychotic

Other products in "International"